Summary
- Current Price
- As of today, XERS price is $15.20, up +16.21% on
- Current Price All-Time High
- XERS price is currently -45.68% below its historical high of $27.98 set on
- Market Cap
- XERS current market cap is $3B, up +117.15% over the past 365 days
- Revenue
- XERS current annual revenue is $291.85M, up +43.72% year-over-year
- Next Earnings
- As of today, the next earnings release for XERS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Xeris Biopharma Holdings, Inc. |
| Ticker | NASDAQ: XERS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | xerispharma.com |
| Employees | 394 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $15.20 | |
| Price, 1D Change | +16.21% | |
| $3B | ||
| - | ||
| - | ||
| 0.20 | ||
| $291.85M | ||
| Revenue, 1Y Change | +43.72% | |
| $0.00 | ||
| EPS, 1Y Change | +100.86% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| EPS Estimate | -$0.09 | N/A |
| EPS Est. Change | -2,912.50% | N/A |
| $291.85M | ||
| Revenue Estimate | $387.90M | N/A |
| Revenue Est. Change | +32.91% | N/A |
| Current Price | $15.20 | |
| Price Target | $12.00 | - |
| Price Tgt. Change | -21.05% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.25 | -$0.37 | -52.49% | |
| $0.06 | $0.00 | -94.92% | |
| -$0.09 | N/A | -2,912.50% | |
| $0.20 | N/A | +6,046.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $201.51M | $203.07M | +0.77% | |
| $292.00M | $291.85M | -0.05% | |
| $387.90M | N/A | +32.91% | |
| $480.03M | N/A | +64.48% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $15.20 | |
| $7.61 | ||
| $9.62 | ||
| $8.18 | ||
| $10.00 | ||
| $0.78 | ||
| 0.20 | ||
| $0.79 | ||
| 82.41 | ||
| 143.61% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $291.85M | ||
| $0.00 | ||
| $238.43M | ||
| 81.70% | ||
| $24.90M | ||
| 8.53% | ||
| $554.00K | ||
| 0.19% | ||
| $37.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 18.85 | ||
| 2.19 | ||
| 1.57 | ||
| - | ||
| - | ||
| 3.34 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $13.69M | ||
| $111.04M | ||
| $392.94M | ||
| $240.31M | ||
| $379.25M | ||
| $109.57M | ||
| $258.10M | ||
| $6.23M | ||
| $3.08M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $291.29M | ||
| $213.54M | ||
| $53.41M | ||
| $0.00 | ||
| $12.69M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $28.63M | ||
| -$696.00K | ||
| $11.39M | ||
| $696.00K | ||
| $27.93M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Barclays | → | |
| Leerink Partners | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Barclays | ||
| Piper Sandler | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with XERS
FAQ
- What is the ticker symbol for Xeris Biopharma Holdings, Inc.?
- The ticker symbol for Xeris Biopharma Holdings, Inc. is NASDAQ:XERS
- Does Xeris Biopharma Holdings, Inc. pay dividends?
- No, Xeris Biopharma Holdings, Inc. does not pay dividends
- What sector is Xeris Biopharma Holdings, Inc. in?
- Xeris Biopharma Holdings, Inc. is in the Healthcare sector
- What industry is Xeris Biopharma Holdings, Inc. in?
- Xeris Biopharma Holdings, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Xeris Biopharma Holdings, Inc. based in?
- Xeris Biopharma Holdings, Inc. is headquartered in United States
- When did Xeris Biopharma Holdings, Inc. go public?
- Xeris Biopharma Holdings, Inc. initial public offering (IPO) was on June 21, 2018
- Is Xeris Biopharma Holdings, Inc. in the S&P 500?
- No, Xeris Biopharma Holdings, Inc. is not included in the S&P 500 index
- Is Xeris Biopharma Holdings, Inc. in the NASDAQ 100?
- No, Xeris Biopharma Holdings, Inc. is not included in the NASDAQ 100 index
- Is Xeris Biopharma Holdings, Inc. in the Dow Jones?
- No, Xeris Biopharma Holdings, Inc. is not included in the Dow Jones index
- When was Xeris Biopharma Holdings, Inc. last earnings report?
- Xeris Biopharma Holdings, Inc.'s most recent earnings report was on November 5, 2026
- When does Xeris Biopharma Holdings, Inc. report earnings?
- The date for Xeris Biopharma Holdings, Inc.'s next earnings report has not been announced yet
Data Sources & References
- XERS Official Website www.xerispharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709626000016/0001867096-26-000016-index.htm
- XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
- XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers